Department of Urology, Kyungpook National University Hospital, Daegu, Korea.
Department of Urology, Kyungpook National University Chilgok Hospital, Daegu, Korea.
Urol J. 2021 Jan 30;18(1):66-73. doi: 10.22037/uj.v16i7.6350.
This study aims to evaluate whether preoperative serum albumin-to-globulin ratio (AGR) could predict the prognosis of patients with urothelial bladder cancer (UBC) after radical cystectomy (RC).
A total of 176 patients with UBC who underwent RC in a tertiary hospital between 2008 and 2019 were retrospectively analyzed. The AGR was calculated as albumin/(total protein - albumin). In addition, the AGR was divided into two groups for the time-dependent receiver operating characteristic curve (ROC) analysis. Survival was estimated using the Kaplan-Meier analysis and compared using the log-rank test. Cox proportional- hazards models were used for multivariate survival analysis.
The best cutoff AGR value for metastasis prediction was 1.32 based on the ROC curve analysis. Patients who had lower pretreatment AGR (<1.32) values composed the low-AGR group (n = 57; 32.4%). On the other hand, the remaining patients (n = 119; 67.6%) composed the high-AGR group. The patients in the low-AGR group had more advanced stage tumors compared with the patients in the high-AGR group. The Kaplan-Meier curves revealed that the patients in the low-AGR group had significantly lower rates of metastasis-free survival (MFS) and cancer-specific survival (CSS). The multivariate Cox regression analysis showed that preoperative AGR was an independent prognostic factor for MFS and CSS.
In this single-institution retrospective study, lower preoperative AGR values demonstrated a poor prognostic effect on MFS and CSS in patients with UBC who underwent RC.
本研究旨在评估术前血清白蛋白-球蛋白比值(AGR)能否预测接受根治性膀胱切除术(RC)的膀胱癌患者的预后。
回顾性分析了 2008 年至 2019 年期间在一家三级医院接受 RC 的 176 例膀胱癌患者。AGR 计算为白蛋白/(总蛋白-白蛋白)。此外,根据时间依赖性接受者操作特征曲线(ROC)分析将 AGR 分为两组。采用 Kaplan-Meier 分析估计生存情况,并采用对数秩检验进行比较。采用 Cox 比例风险模型进行多变量生存分析。
ROC 曲线分析显示,预测转移的最佳 AGR 截断值为 1.32。术前 AGR 值较低(<1.32)的患者组成低 AGR 组(n=57;32.4%)。另一方面,其余患者(n=119;67.6%)组成高 AGR 组。低 AGR 组患者的肿瘤分期较高级别,与高 AGR 组患者相比。Kaplan-Meier 曲线显示,低 AGR 组患者的无转移生存(MFS)和癌症特异性生存(CSS)率显著降低。多变量 Cox 回归分析显示,术前 AGR 是 MFS 和 CSS 的独立预后因素。
在这项单中心回顾性研究中,术前较低的 AGR 值表明接受 RC 的膀胱癌患者的 MFS 和 CSS 预后较差。